Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › NY Department of Health Approves Personalis' ACE Exome Testing

NY Department of Health Approves Personalis' ACE Exome Testing

Apr 24, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Diagnostic sequencing firm Personalis announced it has received approval from the New York State Department of Health for two clinical tests based on its ACE Exome for Inherited Disorders offering.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Sequencing

  1. Maverick Therapeutics to Use Inivata's Liquid Biopsy Assay in Phase I/II Clinical Study

  2. Biodesix Prices $72M IPO

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.